mRNA vaccines — a new era in vaccinology

Pardi, Norbert, Hogan, Michael J., Porter, Frederick W., Weissman, Drew·2018·Nature Reviews Drug Discovery

DOI 10.1038/nrd.2017.243

Cited by (1,011)

Items 101–200 of 1,011

Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan, Marc Jozef Madou, Sourav Kalra, Vianni Chopra, Deepa Ghosh, Sergio Omar Martinez-Chapa · 2020 · ACS Nano
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, Dominik, Kulkarni, Jayesh A., Leung, Jerry, Chen, Sam, Cullis, Pieter R., van der Meel, Roy · 2020 · Advanced Drug Delivery Reviews
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Llovet, Josep M., Pinyol, Roser, Yarchoan, Mark, Singal, Amit G., Marron, Thomas U., Schwartz, Myron, Pikarsky, Eli, Kudo, Masatoshi, Finn, Richard S. · 2024 · Nature Reviews Clinical Oncology
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, Jee Young, Thone, Melissa N., Kwon, Young Jik · 2021 · Advanced Drug Delivery Reviews
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
Linares-Fernández, Sergio, Lacroix, Céline, Exposito, Jean-Yves, Verrier, Bernard · 2020 · Trends in Molecular Medicine
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines
Xiang Liu, Yu Zhang, Shurong Zhou, Lauren Dain, Lei Mei, Guizhi Zhu · 2022 · Journal of Controlled Release
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson · 2022 · Chemical Reviews
Progress, challenges and opportunities in fish vaccine development
Alexandra Adams · 2019 · Fish & Shellfish Immunology
Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
Orlandini von Niessen, Alexandra G., Poleganov, Marco A., Rechner, Corina, Plaschke, Arianne, Kranz, Lena M., Fesser, Stephanie, Diken, Mustafa, Löwer, Martin, Vallazza, Britta, Beissert, Tim et al. · 2019 · Molecular Therapy
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya I. Laczko, Michael J. Hogan, Sushila A. Toulmin, Philip D. Hicks, Katlyn Lederer, Brian T. Gaudette, Diana Castaño, Fatima Amanat, Hiromi Muramatsu, Thomas H. Oguin et al. · 2020 · Immunity
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz Xaver Heinz, Karin Stiasny · 2021 · npj Vaccines
mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
Xu, Shuqin, Yang, Kunpeng, Li, Rose, Zhang, Lu · 2020 · International Journal of Molecular Sciences
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P. Arevalo, Marcus J. Bolton, Valerie Le Sage, Naiqing Ye, Colleen Furey, Hiromi Muramatsu, Mohamad‐Gabriel Alameh, Norbert Pardi, Elizabeth M. Drapeau, Kaela Parkhouse et al. · 2022 · Science
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Weissman, Drew, Alameh, Mohamad-Gabriel, de Silva, Thushan, Collini, Paul, Hornsby, Hailey, Brown, Rebecca, LaBranche, Celia C., Edwards, Robert J., Sutherland, Laura, Santra, Sampa et al. · 2021 · Cell Host & Microbe
RNA modifications in physiology and disease: towards clinical applications
Sylvain Delaunay, Mark Helm, Michaela Frye · 2023 · Nature Reviews Genetics
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, Cynthia Liu, Steven Watkins, Qiongqiong Angela Zhou · 2021 · ACS Central Science
Impact of mRNA chemistry and manufacturing process on innate immune activation
Nelson, Jennifer, Sorensen, Elizabeth W., Mintri, Shrutika, Rabideau, Amy E., Zheng, Wei, Besin, Gilles, Khatwani, Nikhil, Su, Stephen V., Miracco, Edward J., Issa, William J. et al. · 2020 · Science Advances
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery
Masatoshi Maeki, Shuya Uno, Ayuka Niwa, Yuto Okada, Manabu Tokeshi · 2022 · Journal of Controlled Release
Gene therapy: Comprehensive overview and therapeutic applications
Nilofer Sayed, Prince Allawadhi, Amit Khurana, Vishakha Singh, Umashanker Navik, Sravan Kumar Pasumarthi, Isha Khurana, Anil Kumar Banothu, Ralf Weiskirchen, Kala Kumar Bharani · 2022 · Life Sciences
Three decades of messenger RNA vaccine development
Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Dewitte, Heleen · 2019 · Nano Today
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver
Miao, Lei, Lin, Jiaqi, Huang, Yuxuan, Li, Linxian, Delcassian, Derfogail, Ge, Yifan, Shi, Yunhua, Anderson, Daniel G. · 2020 · Nature Communications
Current approaches of nanomedicines in the market and various stage of clinical translation
Xiaoting Shan, Xiang Gong, Jie Li, Jingyuan Wen, Yaping Li, Zhiwen Zhang · 2022 · Acta Pharmaceutica Sinica B
Immune-mediated approaches against COVID-19
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich‐Koubi, Rita C. Acúrcio, Bárbara Carreira, Eilam Yeini, Galia Tiram, Yulia Liubomirski, Ronit Satchi‐Fainaro · 2020 · Nature Nanotechnology
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, Mehdi Mohammadi, Mohammad Hossein Razizadeh, Diana Turner, Raymond Joseph Turner · 2021 · Vaccines
Nucleic acid delivery for therapeutic applications
Akash Gupta, Jason L. Andresen, Rajith S. Manan, Róbert Langer · 2021 · Advanced Drug Delivery Reviews
Emerging Concepts and Technologies in Vaccine Development
Morgan E. Brisse, Sophia M. Vrba, Natalie M. Kirk, Yuying Liang, Hinh Ly · 2020 · Frontiers in Immunology
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Daniela Cornelia Călina, Anca Oana Docea, Demetrios Petrakis, Alexey M. Egorov, Aydar A. Ishmukhametov, Alexsandr Gabibov, М.И. Штильман, Ronald Neil Kostoff, Félix Dias Carvalho, Marco Vinceti et al. · 2020 · International Journal of Molecular Medicine
The interaction of innate immune and adaptive immune system
Ruyuan Wang, Caini Lan, Kamel Benlagha, Niels Olsen Saraiva Câmara, Heather E. Miller, Masato Kubo, Steffen Heegaard, Pamela P. W. Lee, Lu Yang, Huamei Fu Forsman et al. · 2024 · MedComm
mRNA vaccines for COVID-19: what, why and how
Park, Jung Woo, Lagniton, Philip N.P., Liu, Yu, Xu, Ren-He · 2021 · International Journal of Biological Sciences
Efficacy and safety of COVID-19 vaccines in older people
Roy Louis Soiza, Chiara Scicluna, Emma C. Thomson · 2020 · Age and Ageing
COVID-19 mRNA vaccines: Platforms and current developments
Szabó, Gábor Tamás, Mahiny, Azita Josefine, Vlatkovic, Irena · 2022 · Molecular Therapy
The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy
Valentina Francia, Raymond Michel Schiffelers, Pieter R. Cullis, Dominik Witzigmann · 2020 · Bioconjugate Chemistry
A materials-science perspective on tackling COVID-19
Zhongmin Tang, Na Kong, Xingcai Zhang, Yuan Liu, Ping Hu, Shan Mou, Peter Liljeström, Jianlin Shi, Weihong Tan, Jong Seung Kim et al. · 2020 · Nature Reviews Materials
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs
Yuta Suzuki, Hiroshi Ishihara · 2021 · Drug Metabolism and Pharmacokinetics
Recent progress in non-native nucleic acid modifications
Luke K. McKenzie, Roberto El-Khoury, James D. Thorpe, Masad José Damha, Marcel Hollenstein · 2021 · Chemical Society Reviews
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
István Tombácz, Dorottya I. Laczko, Hamna Shahnawaz, Hiromi Muramatsu, Ambika Natesan, Amir Yadegari, Tyler Ellis Papp, Mohamad‐Gabriel Alameh, Vladimir V. Shuvaev, Barbara L. Mui et al. · 2021 · Molecular Therapy
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Marina Luchner, Sören Reinke, Anita Milicic · 2021 · Pharmaceutics
Emerging non-viral vectors for gene delivery
Chenfei Wang, Chaolan Pan, Haiyang Yong, Feifei Wang, Tao Bo, Yitong Zhao, Bin Ma, Wei He, Ming Li · 2023 · Journal of Nanobiotechnology
An Update on Self-Amplifying mRNA Vaccine Development
Blakney, Anna K., Ip, Shell, Geall, Andrew J. · 2021 · Vaccines
The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA
Pratikkumar Patel, Nurudeen Mohammed Ibrahim, Kun Cheng · 2021 · Trends in Pharmacological Sciences
DNA vaccines against COVID-19: Perspectives and challenges
Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira, Marcelo Mendonça · 2020 · Life Sciences
Role of nanotechnology behind the success of mRNA vaccines for COVID-19
Amit Khurana, Prince Allawadhi, Isha Khurana, Sachin Allwadhi, Ralf Weiskirchen, Anil Kumar Banothu, Deepak Chhabra, Kamaldeep Joshi, Kala Kumar Bharani · 2021 · Nano Today
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Volkan Granit, Michael G Benatar, Metin Kurtoğlu, Miloš D. Miljković, Nizar Chahin, Gregory A. Sahagian, Marc H. Feinberg, Adam D. Slansky, Tuan Vu, Christopher M. Jewell et al. · 2023 · The Lancet Neurology
Regulation and functions of non-m6A mRNA modifications
Hanxiao Sun, Kai Li, Cong Liu, Chengqi Yi · 2023 · Nature Reviews Molecular Cell Biology
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman · 2024 · The Lancet
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Pardi, Norbert, Parkhouse, Kaela, Kirkpatrick, Ericka, McMahon, Meagan, Zost, Seth J., Mui, Barbara L., Tam, Ying K., Karikó, Katalin, Barbosa, Christopher J., Madden, Thomas D. et al. · 2018 · Nature Communications
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of <i>in vivo</i> imaging
Jung, Han Na, Lee, Seok-Yong, Lee, Somin, Youn, Hyewon, Im, Hyung-Jun · 2022 · Theranostics
Progress and Prospects on Vaccine Development against SARS-CoV-2
Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng, Quanming Zou · 2020 · Vaccines
The evolution and future of influenza pandemic preparedness
Walter N. Harrington, Christina M. Kackos, Richard J. Webby · 2021 · Experimental & Molecular Medicine
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Emily Bettini, Michela Locci · 2021 · Vaccines
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
Margaret M. Billingsley, Ningqiang Gong, Alvin J. Mukalel, Ajay S. Thatte, Rakan D. El-Mayta, Savan K. Patel, Ann E. Metzloff, Kelsey L. Swingle, Xuexiang Han, Lulu Xue et al. · 2023 · Small
Myocarditis following COVID-19 mRNA vaccination
Abu Mouch, Saif, Roguin, Ariel, Hellou, Elias, Ishai, Amorina, Shoshan, Uri, Mahamid, Lamis, Zoabi, Marwan, Aisman, Marina, Goldschmid, Nimrod, Berar Yanay, Noa · 2021 · Vaccine
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Robinson, Ema, MacDonald, Kelvin D., Slaughter, Kai, McKinney, Madison, Patel, Siddharth, Sun, Conroy, Sahay, Gaurav · 2018 · Molecular Therapy
Principles for designing an optimal mRNA lipid nanoparticle vaccine
Kon, Edo, Elia, Uri, Peer, Dan · 2022 · Current Opinion in Biotechnology
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment
Yuxin Yan, Woo In Shin, Yoong Xin Pang, Meng Yang, Jianchen Lai, Chong You, Haitao Zhao, Edward Henry Lester, Tao Wu, Cheng Heng Pang · 2020 · International Journal of Environmental Research and Public Health
Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm
Lining Zheng, Sarith R. Bandara, Zhengzhong Tan, Cecília Leal · 2023 · Proceedings of the National Academy of Sciences
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, Adam K. Wheatley, Danijela Zukancic, Azizah Algarni, Hareth A. Al-Wassiti, Thomas Paul Davis, Colin William Pouton, Stephen John Kent et al. · 2021 · Acta Biomaterialia
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu · 2024 · Signal Transduction and Targeted Therapy
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
Ho, William, Gao, Mingzhu, Li, Fengqiao, Li, Zhongyu, Zhang, Xue‐Qing, Xu, Xiaoyang · 2021 · Advanced Healthcare Materials
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy · 2021 · Nature reviews. Immunology
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
Maria L. Guevara, Francesca Persano, Stefano Persano · 2020 · Frontiers in Chemistry
mRNA Vaccines in the COVID-19 Pandemic and Beyond
Michael J. Hogan, Norbert Pardi · 2021 · Annual Review of Medicine
Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
Kim, Sun Chang, Sekhon, Simranjeet Singh, Shin, Woo-Ri, Ahn, Gna, Cho, Byung-Kwan, Ahn, Ji-Young, Kim, Yang-Hoon · 2022 · Molecular & Cellular Toxicology
Controlling timing and location in vaccines
Darrell J. Irvine, Aereas Aung, Murillo Silva · 2020 · Advanced Drug Delivery Reviews
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Bok, Karin, Sitar, Sandra, Graham, Barney S., Mascola, John R. · 2021 · Immunity
Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
M. Mascellino, Federica Di Timoteo, M. De Angelis, A. Oliva · 2021 · Infection and Drug Resistance
Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling
Hongxia Zhang, Xinru You, Xiaojuan Wang, Lei Cui, Zining Wang, Feifei Xu, Mengyun Li, Zhenggang Yang, Jinyun Liu, Peng Huang et al. · 2021 · Proceedings of the National Academy of Sciences
Lipid nanoparticles in the development of mRNA vaccines for COVID-19
Barnabas Wilson, K.M. Geetha · 2022 · Journal of Drug Delivery Science and Technology
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
Xuexiang Han, Mohamad‐Gabriel Alameh, Kamila Butowska, James J. Knox, Kendall A. Lundgreen, Majed Ghattas, Ningqiang Gong, Lulu Xue, Ying Xu, Marc Lavertu et al. · 2023 · Nature Nanotechnology
Rapid Surface Display of mRNA Antigens by Bacteria‐Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine
Li, Yao, Ma, Xiaotu, Yue, Yale, Zhang, Kaiyue, Cheng, Keman, Feng, Qingqing, Ma, Nana, Liang, Jie, Zhang, Tianjiao, Zhang, Lizhuo et al. · 2022 · Advanced Materials
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, Xing Huang, Tingbo Liang · 2023 · Signal Transduction and Targeted Therapy
Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong, Meng Cui, Zeyu Cao, Chenjue Tang, Zhen Tian, Yuping Hu, Yu Zhao, Shaoyi Jiang · 2024 · Vaccines
Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies
Hongjian Li, Kun Peng, Kai Yang, Wenbo Ma, Shaolong Qi, Xinyang Yu, Jia He, Xin Lin, Guocan Yu · 2022 · Theranostics
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
Greaney, Allison J., Loes, Andrea N., Gentles, Lauren E., Crawford, Katharine H.D., Starr, Tyler N., Malone, Keara D., Chu, Helen Y., Bloom, Jesse D. · 2021 · Science Translational Medicine
Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
Colin J. McKinlay, Nancy L. Benner, Ole Audun Werner Haabeth, Robert M. Waymouth, Paul A. Wender · 2018 · Proceedings of the National Academy of Sciences
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
Basmah Nasser Aldosari, Iman Mohammed Alfagih, Alanood S. Almurshedi · 2021 · Pharmaceutics
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Zhang, Lizhou, More, Kunal R., Ojha, Amrita, Jackson, Cody B., Quinlan, Brian D., Li, Hao, He, Wenhui, Farzan, Michael, Pardi, Norbert, Choe, Hyeryun · 2023 · npj Vaccines
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer · 2024 · Nature Reviews Drug Discovery
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
Parhiz, Hamideh, Shuvaev, Vladimir V., Pardi, Norbert, Khoshnejad, Makan, Kiseleva, Raisa Yu, Brenner, Jacob S., Uhler, Thomas, Tuyishime, Steven, Mui, Barbara L., Tam, Ying K. et al. · 2018 · Journal of Controlled Release
An RNA toolbox for cancer immunotherapy
Pastor, Fernando, Berraondo, Pedro, Etxeberria, Iñaki, Frederick, Josh, Sahin, Ugur, Gilboa, Eli, Melero, Ignacio · 2018 · Nature Reviews Drug Discovery
How can nanotechnology help to combat COVID-19? Opportunities and urgent need
Estefânia Vangelie Ramos Campos, Anderson do Espírito Santo Pereira, Jhones Luiz de Oliveira, Lucas Bragança Carvalho, Mariana Guilger‐Casagrande, Renata de Lima, Leonardo Fernandes Fraceto · 2020 · Journal of Nanobiotechnology
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez‐Gascón, Maria Ángelés Solinís, Ana del Pozo‐Rodríguez · 2020 · Nanomaterials
Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
Pedro Pires Goulart Guimarães, Rui Zhang, Roman Spektor, Mingchee Tan, Amanda Chung, Margaret M. Billingsley, Rakan D. El-Mayta, Rachel Riley, Lili Wang, James M. Wilson et al. · 2019 · Journal of Controlled Release
Bioinspired and green synthesis of nanoparticles from plant extracts with antiviral and antimicrobial properties: A critical review
Gowhar A. Naikoo, Mujahid Mustaqeem, Israr U. Hassan, Tasbiha Awan, Fareeha Arshad, Hiba Salim, Ahsanulhaq Qurashi · 2021 · Journal of Saudi Chemical Society
Ionizable lipid nanoparticles for in utero mRNA delivery
Riley, Rachel S., Kashyap, Meghana V., Billingsley, Margaret M., White, Brandon, Alameh, Mohamad-Gabriel, Bose, Sourav K., Zoltick, Philip W., Li, Hiaying, Zhang, Rui, Cheng, Andrew Y. et al. · 2021 · Science Advances
Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
Mohammad Ariful Islam, Rice Jamie, Emma Reesor, Harshal R. Zope, Wei Tao, Michael Lim, Jianxun Ding, Yunhan Chen, Dike Aduluso, Bruce R. Zetter et al. · 2020 · Biomaterials
New opportunities for nanoparticles in cancer immunotherapy
Wooram Park, Young-Jae Heo, Dong Keun Han · 2018 · Biomaterials Research
Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick G. Walker, Yizhou Dong · 2020 · Current topics in microbiology and immunology
Biologics, theranostics, and personalized medicine in drug delivery systems
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, Stefano Giovagnoli, Maurizio Ricci · 2024 · Pharmacological Research
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
Xiangrong Song, Chao Liu, Ning Wang, Hai Huang, Siyan He, Changyang Gong, Yuquan Wei · 2020 · Advanced Drug Delivery Reviews
Non-viral COVID-19 vaccine delivery systems
Kyung Soo Park, Xiaoqi Sun, Marisa E. Aikins, James Jaehyun Moon · 2020 · Advanced Drug Delivery Reviews
Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture
Zoltán Kis, Robin J. Shattock, Nilay Shah, Cleo Kontoravdi · 2018 · Biotechnology Journal
Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
Annette I.S. van den Berg, Chae‐Ok Yun, Raymond Michel Schiffelers, Wim E. Hennink · 2021 · Journal of Controlled Release
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, Gunilla Åkesson Nilsson, David B. Volkin, Enrico Mastrobattista, Örn Almarsson, Daan J.A. Crommelin · 2022 · Journal of Pharmaceutical Sciences
Interpretable RNA Foundation Model from Unannotated Data for Highly Accurate RNA Structure and Function Predictions
Chen, Jiayang, Hu, Zhihang, Sun, Siqi, Tan, Qingxiong, Wang, Yixuan, Yu, Qinze, Zong, Licheng, Hong, Liang, Xiao, Jin, Shen, Tao et al. · 2022
Automated model-predictive design of synthetic promoters to control transcriptional profiles in bacteria
LaFleur, Travis L., Hossain, Ayaan, Salis, Howard M. · 2022 · Nature Communications
Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
Blakney, Anna K., McKay, Paul F., Yus, Bárbara Ibarzo, Aldon, Yoann, Shattock, Robin J. · 2019 · Gene Therapy
Advances in Circular RNA and Its Applications
Xian Zhao, Youxiu Zhong, Xudong Wang, Jiuheng Shen, Wenlin An · 2022 · International Journal of Medical Sciences
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
Aldrich, Cassandra, Leroux–Roels, Isabel, Huang, Katell Bidet, Bica, Mihai Alexandru, Loeliger, Edde, Schoenborn-Kellenberger, Oliver, Walz, Lisa, Leroux-Roels, Geert, von Sonnenburg, Frank, Oostvogels, Lidia · 2021 · Vaccine
Lipid nanoparticles for siRNA delivery in cancer treatment
Souhaila H. El Moukhtari, Elisa Garbayo, Ane Amundarain, Simon Pascual‐Gil, Arantxa Carrasco‐Leon, Felipe Prósper, Xabier Agirre, María J. Blanco‐Prieto · 2023 · Journal of Controlled Release